Editors' pick: Originally published Nov. 1.

Stocks slipped on Tuesday in a weaker start to November as uncertainty over the upcoming presidential election weighed on Wall Street. 

The S&P 500 was down 0.2%, the Dow Jones Industrial Average fell 0.16%, and the Nasdaq declined 0.23%. The S&P 500 has fallen for the past six sessions. 

Conflicting polls created uncertainty over the outcome of the U.S. presidential election. An NBC/SurveyMonkey poll showed Democratic presidential candidate Hillary Clinton's 6-point lead remained after concerns over her emails were raised again on Friday. A separate ABC poll showed Republican presidential candidate Donald Trump with a 1-point lead. U.S. voters will head to the polls on Nov. 8. 

Manufacturing activity in the U.S. in October rose at a faster pace than expected, according to the latest ISM Manufacturing Index. The measure increased to 51.9 last month from 51.5 in October. Analysts expected a reading of 51.7.

A separate reading on the manufacturing sector hit a one-year high as increases in output and new orders drove manufacturing activity. The final Markit PMI reading for October increased to 53.4 in its final reading for the month, up from initial estimates of 53.3.

U.S. construction spending fell 0.4% in September, according to the Census Bureau. Analysts had expected a 0.5% increase after spending declined 0.5% in August.

Manufacturing activity in China improved in October to its best level in two years. The official manufacturing purchasing managers index rose to 51.2 in October, up from 50.4 in September, according to the National Bureau of Statistics. The measure has improved for three straight months. Improvement in the sector comes as a relief after stretches of weak growth in the manufacturing-focused economy.

Kellogg (K) increased 0.4% as cost cuts and improved margins boosted third-quarter earnings 42%. Adjusted profit jumped to 96 cents a share from 85 cents a year earlier. Analysts had expected earnings of 87 cents a share. Revenue fell 2.2% as currency exchange dragged on topline growth.

Royal Dutch Shell (RDS.A) jumped 4% after swinging to a profit in its third quarter. The oil company reported quarterly profit of $1.4 billion, reversing a loss of $6.1 billion in the year-ago quarter. Shell managed to turn a profit as it focused on cost cutting in the face of a prolonged period of low oil prices.

BP (BP) also reported a better-than-expected quarter as it stripped down operations to weather a tough climate. Third-quarter profit rose 35% after three straight quarters of net losses.

Archer Daniels (ADM) rose 8% after earnings topped estimates thanks to a jump in agricultural services revenue. Third-quarter net income improved to 58 cents a share from 41 cents in the year-ago quarter. Adjusted earnings came in at 59 cents a share, above estimates of 46 cents.

Pfizer (PFE) fell 1% after issuing a disappointing outlook for earnings. The drugmaker said it expects full-year earnings of $2.38 to $2.43 a share, narrowing the upper-range of its guidance from $2.48. Analysts had anticipated full-year earnings of $2.46 a share. Pfizer also missed third-quarter profit, reporting adjusted net income of 61 cents a share, a penny below estimates. Revenue rose 8% and came in roughly in line with consensus.

Shire (SHPG)  cut its full-year outlook as costs associated with its acquisition of Baxalta rose. The drugmaker expected a diluted loss per American Depository Share of 70 cents to $1.10 this year. The company had previously expected zero earnings to a net loss of 40 cents a share. 

Gannett (GCI) jumped 6% after abandoning its bid to purchase newspaper publisher Tronc (TRNC) . The two had failed to reach an agreement on price after months of talks. Tronc shares slumped 15%.

Coach (COH) shares were under pressure after the fashion accessories retailer missed quarterly sales estimates. The company reported a 1% increase in revenue to $1.04 billion, though coming in short of $1.07 billion consensus. Coach forecasts fiscal 2017 revenue growth in the low-to-mid single digits.

Angie's List (ANGI) climbed more than 10% after announcing it had hired financial advisers to explore a potential sale. A sale would be among a number of strategic options the company could pursue. The home-improvement search engine reported a wider quarterly loss than expected, though new memberships rose.

Three-fifths of S&P 500 companies have reported earnings so far this season. Of those that have reported, 73% have exceeded earnings estimates, while 55% have passed revenue forecasts. Third-quarter earnings are expected to grow 3.1%, according to Thomson Reuters, snapping the longest earnings recession since 2009.

General Motors (GM) added 1% after breezing past sales estimates over October. The automaker reported a 1.7% decline in unit sales to 258,626, far better than an expected 6.1% decline. October had two fewer selling days this year than the last. 

Fiat Chrysler (FCAU) sales reported a sharper-than-expected decline in October. The automaker reported a 10% decline in unit sales to 176,609. Analysts had anticipated a 7.9% decline. Car sales spiraled 33% lower, while truck sales jumped 12%. 

Ford (F) postponed its October sales report until later this week. The automaker said the delay was tied to a fire at its corporate headquarters in Michigan. Analysts anticipate an 11% decline when the results are released. 

Crude oil prices rebounded on Tuesday morning, though worries over a deal among major oil-producing countries persisted. Goldman Sachs added to a chorus of concern on Monday evening after warning that prices could plummet if the Organization of Petroleum Exporting Countries fails to enact a production freeze agreement at a meeting in late November. 

A deal looks more and more distant, analysts wrote in a note, with "weakening oil fundamentals warranting oil prices in the low [$40 a barrel range] in our view if OPEC is unable to deliver a convincing agreement."

West Texas Intermediate crude climbed 0.8% to $47.23 a barrel on Tuesday morning. 

The Federal Open Market Committee convened on Tuesday morning to discuss monetary policy. The Federal Reserve's policy-making group will conclude the meeting on Wednesday afternoon with a statement, but no press conference is scheduled.

"While the market is widely anticipating the Fed to keep policy unchanged in Wednesday's announcement, the statement itself should hold plenty of clues as to the Fed's objective for rates at the final meeting of 2016," said Lindsey M. Piegza, chief economist at Stifel. "If it's anything like last year, and the Fed intends to follow through with a year-end hike, the language this month will no doubt provide specific guidance; reinforcing expectations for another increase come December."

Valeant Pharmaceuticals (VRX) dropped sharply in the final hour of trading on Monday on reports its former CEO and chief financial officer are the focus of a criminal probe. Ex-CEO Michael Pearson and ex-CFO Howard Schiller are the focus of the U.S. Department of Justice investigation. The probe centers around possible accounting fraud. The stock rose 3.9% early Tuesday.

If you liked this article you might like

Which Hot Biotech Name Will Be Acquired Next?

Which Hot Biotech Name Will Be Acquired Next?

Pfizer CEO Ian Read Gets 61% Raise to Keep Him From Considering Retirement

Pfizer CEO Ian Read Gets 61% Raise to Keep Him From Considering Retirement

Bret Jensen's Biotech Mailbag

Bret Jensen's Biotech Mailbag

Senator Asks Drug Companies What They'll Do With Extra Cash From Big Tax Cut

Senator Asks Drug Companies What They'll Do With Extra Cash From Big Tax Cut

Profit With Technical Analysis: Cramer's 'Mad Money' Recap (Tuesday 2/20/18)

Profit With Technical Analysis: Cramer's 'Mad Money' Recap (Tuesday 2/20/18)